BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17590270)

  • 21. Vav1 increases Bcl-2 expression by selective activation of Rac2-Akt in leukemia T cells.
    Wan YJ; Yang Y; Leng QL; Lan B; Jia HY; Liu YH; Zhang CZ; Cao Y
    Cell Signal; 2014 Oct; 26(10):2202-9. PubMed ID: 24880064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vav1 regulates MHCII expression in murine resting and activated B cells.
    Jux B; Staratschek-Jox A; Penninger JM; Schultze JL; Kolanus W
    Int Immunol; 2013 May; 25(5):307-17. PubMed ID: 23391492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The gp130 Cytokine Interleukin-11 Regulates Engraftment of Vav1
    De Vita S; Li Y; Harris CE; McGuinness MK; Ma C; Williams DA
    Stem Cells; 2018 Mar; 36(3):446-457. PubMed ID: 29235178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vav1 in differentiation of tumoral promyelocytes.
    Bertagnolo V; Brugnoli F; Grassilli S; Nika E; Capitani S
    Cell Signal; 2012 Mar; 24(3):612-20. PubMed ID: 22133616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
    Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
    Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rho GTPases and regulation of hematopoietic stem cell localization.
    Williams DA; Zheng Y; Cancelas JA
    Methods Enzymol; 2008; 439():365-93. PubMed ID: 18374178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vav1 modulates protein expression during ATRA-induced maturation of APL-derived promyelocytes: a proteomic-based analysis.
    Bertagnolo V; Grassilli S; Bavelloni A; Brugnoli F; Piazzi M; Candiano G; Petretto A; Benedusi M; Capitani S
    J Proteome Res; 2008 Sep; 7(9):3729-36. PubMed ID: 18642942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.
    Morrish E; Wartewig T; Kratzert A; Rosenbaum M; Steiger K; Ruland J
    Eur J Immunol; 2023 Mar; 53(3):e2250147. PubMed ID: 36541400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion.
    Sebban S; Farago M; Rabinovich S; Lazer G; Idelchuck Y; Ilan L; Pikarsky E; Katzav S
    Oncotarget; 2014 Oct; 5(19):9214-26. PubMed ID: 25313137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.
    Fernandez-Zapico ME; Gonzalez-Paz NC; Weiss E; Savoy DN; Molina JR; Fonseca R; Smyrk TC; Chari ST; Urrutia R; Billadeau DD
    Cancer Cell; 2005 Jan; 7(1):39-49. PubMed ID: 15652748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
    Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
    Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vav1 Promotes B-Cell Lymphoma Development.
    Shalom B; Farago M; Salaymeh Y; Sebban S; Pikarsky E; Katzav S
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ha-ras in normal and tumoral tissues: structure, function and regulation.
    Solanas M; Escrich E
    Rev Esp Fisiol; 1996 Sep; 52(3):173-92. PubMed ID: 8974153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular oncogenes and cancer.
    Cooper GM
    Clin Physiol Biochem; 1987; 5(3-4):122-9. PubMed ID: 3621795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vav1 as a central regulator of invadopodia assembly.
    Razidlo GL; Schroeder B; Chen J; Billadeau DD; McNiven MA
    Curr Biol; 2014 Jan; 24(1):86-93. PubMed ID: 24332539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphatidylinositol Monophosphates Regulate Optimal Vav1 Signaling Output.
    Rodríguez-Fdez S; Citterio C; Lorenzo-Martín LF; Baltanás-Copado J; Llorente-González C; Corbalán-García S; Vicente-Manzanares M; Bustelo XR
    Cells; 2019 Dec; 8(12):. PubMed ID: 31888228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ephrin-A1 stimulates migration of CD8+CCR7+ T lymphocytes.
    Hjorthaug HS; Aasheim HC
    Eur J Immunol; 2007 Aug; 37(8):2326-36. PubMed ID: 17634955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
    Bai T; Luoh SW
    Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.